EXOME ASSET MANAGEMENT LLC 13F Portfolio
EXOME ASSET MANAGEMENT LLC runs EXOME ASSET MANAGEMENT LLC and currently holds 52 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $162.10M. Their top holdings are GH, PRAX, TGTX, COGT, IONS. The top five represent 26.8% of reported portfolio weight. EXOME ASSET MANAGEMENT LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, EXOME ASSET MANAGEMENT LLC initiated 11 new positions. They trimmed 29 positions. Their current best-performing preview position is LQDA with returns of +111.26%.
Portfolio Value
$162.10M
Alpha Score
117.6
#0 of 1000
Holdings
52
EXOME ASSET MANAGEMENT LLC Current 13F Holdings
Reported holdings from EXOME ASSET MANAGEMENT LLC's latest SEC 13F filing, ranked by portfolio weight.
52 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 GH GUARDANT HEALTH INC | 6.25% | $24.49 | $167.47 | +583.83% | Trimmed -18.42% |
 PRAX PRAXIS PRECISION MEDICINES I | 5.62% | $46.67 | $259.86 | +456.80% | Trimmed -40.17% |
 TGTX TG THERAPEUTICS INC | 5.59% | $54.94 | $55.37 | +0.78% | New Buy |
 COGT COGENT BIOSCIENCES INC | 5.03% | $5.99 | $31.00 | +417.53% | Trimmed -24.42% |
 IONS IONIS PHARMACEUTICALS INC | 4.31% | $34.84 | $45.28 | +29.97% | Trimmed -19.89% |
 LLY ELI LILLY & CO | 4.06% | $668.72 | $1,178.52 | +76.23% | Trimmed -21.68% |
 ABVX ABIVAX SA | 3.85% | $133.26 | $88.15 | -33.85% | New Buy |
 ALMS ALUMIS INC | 3.55% | $3.99 | $7.16 | +79.45% | Trimmed -26.78% |
 CYTK CYTOKINETICS INC | 3.16% | $47.87 | $62.91 | +31.42% | Trimmed -42.10% |
 ELVN ENLIVEN THERAPEUTICS INC | 3.14% | $15.40 | $40.98 | +166.10% | Trimmed -54.47% |
Showing 1-10 of 52